Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2008 3
2009 2
2010 4
2011 5
2012 4
2013 8
2014 1
2015 2
2016 3
2017 3
2018 7
2019 5
2020 1
2021 7
2022 6
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Precision Medicine 2030.
Pacanowski M, Liu Q. Pacanowski M, et al. Clin Pharmacol Ther. 2020 Jan;107(1):62-64. doi: 10.1002/cpt.1675. Epub 2019 Nov 28. Clin Pharmacol Ther. 2020. PMID: 31782136 No abstract available.
Pharmacogenetic Labeling of FDA-Approved Drugs: A Regulatory Retrospective.
Drozda K, Pacanowski MA, Grimstein C, Zineh I. Drozda K, et al. Among authors: pacanowski ma. JACC Basic Transl Sci. 2018 Aug 28;3(4):545-549. doi: 10.1016/j.jacbts.2018.06.001. eCollection 2018 Aug. JACC Basic Transl Sci. 2018. PMID: 30175278 Free PMC article. Review.
Clinical and regulatory considerations in pharmacogenetic testing.
Schuck RN, Marek E, Rogers H, Pacanowski M. Schuck RN, et al. Among authors: pacanowski m. Am J Health Syst Pharm. 2016 Dec 1;73(23):1999-2006. doi: 10.2146/ajhp160476. Am J Health Syst Pharm. 2016. PMID: 27864207 Free PMC article. Review.
Research Directions in Genetic Predispositions to Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis.
Manolio TA, Hutter CM, Avigan M, Cibotti R, Davis RL, Denny JC, Grenade L, Wheatley LM, Carrington MN, Chantratita W, Chung WH, Dalton AD, Hung SI, Lee MTM, Leeder JS, Lertora JJL, Mahasirimongkol S, McLeod HL, Mockenhaupt M, Pacanowski M, Phillips EJ, Pinheiro S, Pirmohamed M, Sung C, Suwankesawong W, Trepanier L, Tumminia SJ, Veenstra D, Yuliwulandari R, Shear NH. Manolio TA, et al. Among authors: pacanowski m. Clin Pharmacol Ther. 2018 Mar;103(3):390-394. doi: 10.1002/cpt.890. Epub 2017 Nov 6. Clin Pharmacol Ther. 2018. PMID: 29105735 Free PMC article. Review.
Regulatory news: Nulibry (fosdenopterin) approved to reduce the risk of mortality in patients with molybdenum cofactor deficiency type A: FDA approval summary.
Farrell S, Karp J, Hager R, Wang Y, Adeniyi O, Wang J, Li L, Ma L, Peretz J, Summan M, Kong N, White M, Pacanowski M, Price D, Filie J, Donohue K, Joffe H. Farrell S, et al. Among authors: pacanowski m. J Inherit Metab Dis. 2021 Sep;44(5):1085-1087. doi: 10.1002/jimd.12421. Epub 2021 Aug 8. J Inherit Metab Dis. 2021. PMID: 34337775 Review. No abstract available.
Considerations for Developing Targeted Therapies in Low-Frequency Molecular Subsets of a Disease.
Schuck RN, Woodcock J, Zineh I, Stein P, Jarow J, Temple R, Permutt T, LaVange L, Beaver JA, Charlab R, Blumenthal GM, Dorff SE, Leptak C, Lemery S, Rogers H, Chowdhury B, Litwack ED, Pacanowski M. Schuck RN, et al. Among authors: pacanowski m. Clin Pharmacol Ther. 2018 Aug;104(2):282-289. doi: 10.1002/cpt.1041. Epub 2018 Feb 23. Clin Pharmacol Ther. 2018. PMID: 29473145 Free PMC article. Review.
61 results